Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Events
 

EquipNet Auction: Looking to sell your pre-owned equipment? Sell it Now! Don't Wait!

Our Newest Cartoon Illustrates: "Women's History Month"


New Jersey BioHistory

Welcome to "New Jersey BioHistory" a feature section that tells the story of the scientists,
institutions, political leaders, and significant events that are the foundation of the biotechnology
and medical device industries in the state of New Jersey.

Tell us about New Jersey's BioHistory. If you are aware of a notable event, person,
organization/company or accomplishment that we should include,
please send e-mail: BioHistory@InfoResource.org


1848 -- American Association for the Advancement of Science founded.

American Association for the Advancement of Science American Association for the Advancement of Science founded in 1848 marked the emergence of a national scientific community in the United States, and was the first organization established to promote the development of science and engineering at the national level and to represent the interests of all its disciplines.

Today, the AAAS serves nearly 300 affiliated societies and academies of science and publishes the peer-reviewed general science journal Science. The non-profit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives that include science policy, international programs, science education, and public understanding of science.


1859 -- Charles Darwin published "The Origin of Species."

Charles Darwin In 1859, British naturalist Charles Darwin published "On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life" in which he postulated his theory of evolution that explained how the diverse of species on Earth evolved from a simple, singled-celled ancestor.

From 1831-1836, Darwin served as a naturalist aboard the H.M.S. Beagle -- a British science expedition around the world. In South America Darwin discovered fossils of extinct animals that were similar to modern species, and on the Galapagos Islands, located west of Equador, he noticed many variations of plants and animals of the same general type as those in South America. Throughout the expedition Darwin studied plants and animals and collected specimens for further study.

Upon his return to London, Darwin conducted thorough research of his notes and specimens, and out of his study grew several related theories: evolution did occur; evolutionary change was gradual, requiring thousands to millions of years; the primary mechanism for evolution was a process called natural selection; and the millions of species alive today arose from a single original life form through a branching process called "specialization."

Darwin's theory of evolutionary selection holds that variation within species occurs randomly and that the survival or extinction of each organism is determined by that organism's ability to adapt to its environment. Darwin's theory of evolution remains the foundation of modern biology.

Suggested Reading:

From So Simple a Beginning
From So Simple a Beginning: Darwin's Four Great Books (Voyage of the Beagle, The Origin of Species, The Descent of Man, The Expression of Emotions in Man and Animals)

By Charles Darwin, Edward O. Wilson.
Published by W. W. Norton. 2005.
The Reluctant Mr. Darwin
The Reluctant Mr. Darwin: An Intimate Portrait of Charles Darwin and the Making of His Theory of Evolution

By David Quammen.
Published by W. W. Norton. 2006.


1865 -- Gregor Mendel, the father of modern genetics, presents his laws of heredity.

Gregor Mendel "In 1859 I obtained a very fertile descendant with large, tasty seeds from a first generation hybrid. Since in the following year, its progeny retained the desirable characteristics and were uniform, the variety was cultivated in our vegetable garden, and many plants were raised every year up to 1865. (Gregor Mendel to Carl Nägeli, April 1867).

  • MendelWeb: An educational resource for teachers and students.
  • MendelWeb Timeline: Significant events in Mendel's life.
  • Experiments in Plant Hybridization: [Suggested Reading] By Gregor Mendel. 1865. (German and English translations).
  • Versuche über Pflanzen-Hybriden: (Mendel's original paper in German)


1885 -- Johnson & Johnson established in New Brunswick, N.J.

In 1885, Robert Wood Johnson, based on the discoveries of Sir Joseph Lister, an English surgeon who identified airborne germs as a source of infection, formed a partnership with brothers James Wood and Edward Mead Johnson. Their company began operations in New Brunswick, N.J., and was formally incorporated as Johnson & Johnson in 1886. At the time, few hospitals in the United States were large enough to use Lister's methods of antisepsis, and Johnson & Johnson entered the surgical dressings industry.

Today, Johnson & Johnson is one of the largest manufacturers of health care products with nearly 200 affiliate companies worldwide in more than 175 countries.


1887 -- Marine Hospital Service Hygienic Laboratory (National Institutes of Health) founded.

National Institutes of Health The National Institutes of Health (NIH) traces its roots to 1887, when a one-room laboratory was created within the Marine Hospital Service (MHS), predecessor agency to the U.S. Public Health Service (PHS). The MHS was established in 1798 to provide for the medical care of merchant seamen -- charged by Congress with examining passengers on arriving ships for clinical signs of infectious diseases, such as cholera and yellow fever, to prevent epidemics.

During the 1870s and 1880s, scientists in Europe presented compelling evidence that microscopic organisms were the causes of several infectious diseases, and MHS officials closely followed these developments. In 1887, Joseph Kinyoun, a MHS physician trained in the new bacteriological methods, set up a one-room laboratory in the Marine Hospital at Stapleton, Staten Island, New York. Kinyoun called this facility a "laboratory of hygiene" in imitation of German facilities, and within a few months, he identified the cholera bacillus and used his Zeiss microscope to demonstrate it to his colleagues as confirmation of their clinical diagnoses.

Dr. Joseph J. Kinyoun, NIH The Biologics Control Act enacted in 1902 had major consequences for the Hygienic Laboratory. It charged the laboratory with regulating the production of vaccines and antitoxins, making it a regulatory agency four years before passage of the 1906 Pure Food and Drugs Act. The danger posed by biological products that had emerged from bacteriologic discoveries resulted from their production in animals and their administration by injection. In 1901, thirteen children in St. Louis died after receiving diphtheria antitoxin contaminated with tetanus spores. This tragedy spurred Congress to pass the Biologics Control Act, and between 1903-1907 standards were established and licenses issued to pharmaceutical firms for making smallpox and rabies vaccines, diphtheria and tetanus antitoxins, and various other antibacterial antisera. (In 1972, responsibility for regulation of biologics was transferred to the Food and Drug Administration). (Photo: courtesy of the NIH Almanac)

In 1912 MHS was reorganized, renamed the Public Health Service (PHS) and authorized to conduct research into noncontagious diseases and into the pollution of streams and lakes in the U.S. During World War I, the PHS attended primarily to sanitation of areas around military bases in the U.S., and when the 1918 influenza pandemic struck Washington, physicians from the laboratory were pressed into service treating patients in the District of Columbia because so many local doctors had fallen ill. In 1930, the Ransdell Act changed the name of the Hygienic Laboratory to the National Institute of Health (NIH) and authorized the establishment of fellowships for research into basic biological and medical problems. The roots of this act extended to 1918, when chemists who had worked with the Chemical Warfare Service in World War I sought to establish an institute in the private sector to apply fundamental knowledge in chemistry to problems of medicine. In 1937, the National Cancer Institute (NCI) was created with sponsorship from every Senator in Congress, and was authorized to award grants to nonfederal scientists for research on cancer and to fund fellowships at NCI for young researchers.

President Franklin D. Roosevelt dedicated NIH campus, 1940 During World War II, the NIH focused almost entirely on war-related problems. At the close of the war, PHS leaders guided through Congress the 1944 Public Health Service Act, which defined the shape of medical research in the post-war world. Two provisions were especially important: 1) In 1946 the NCI grants program was expanded to the entire NIH, and the program grew from just over $4 million in 1947, to more than $100 million in 1957, and to $1 billion in 1974. The entire NIH budget expanded from $8 million in 1947 to more than $1 billion in 1966, now fondly remembered as "the golden years" of NIH expansion. Accompanying growth in the grants program was the proliferation of new categorical institutes, and from 1946-1949, voluntary health organizations moved Congress to create institutes for research on mental health, dental diseases, and heart disease. In 1948, language in the National Heart Act made the name of the umbrella organization the National Institutes of Health. 2) The 1944 PHS Act authorized NIH to conduct clinical research, and after the war Congress provided funding to build a research hospital, now called the Warren Grant Magnuson Clinical Center on the NIH campus in Bethesda, Maryland. The Center which opened in 1953 with 540 beds was designed to bring research laboratories into close proximity with hospital wards in order to promote productive collaboration between laboratory scientists and clinicians. (Photo: National Archives and Records Administration photograph, courtesy of the Franklin Delano Roosevelt Library, Hyde Park, New York)

The NIH today, part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research and is composed of 27 Institutes and Centers, providing leadership and financial support to researchers in every state and throughout the world.


1897 -- Maxwell W. Becton and Fairleigh S. Dickinson established Becton, Dickinson and Company

In 1897, Maxwell Becton and Fairleigh Dickinson met on a sales trip in Texas and later formed a partnership based in a handshake. They named their medical device company Becton, Dickinson and Company, and the company shortly thereafter establishes their headquarters in East Rutherford, N.J.

Today, BD (Becton, Dickinson and Company) is a leading medical device company, headquartered in Franklin Lakes, NJ, that manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products to healthcare institutions, life science researchers, clinical laboratories, industry and the general public.


1918 -- Spanish Influenza Pandemic.

It is estimated that between 25 and 40 million people died from the the influenza outbreak that began in 1918, swept across America in a week and around the world in three months. In all, between 500,000 and 700,000 Americans --civilians and soldiers-- died from the influenza, more than were lost in World War I, II, and the Korean and Viet Nam wars combined.

Latest Findings: In September 2004, the National Institutes of Health (NIH) awarded a five-year, $12.5 million grant to five institutions that will collaborate to study genes constructed from 1918 flu-virus particles salvaged from the bodies of World War I soldiers and the exhumed Brevig Mission, Alaska resident. The Institutions include the Armed Forces Institute of Pathology, Washington, D.C.; Mount Sinai School of Medicine, New York; Scripps Research Institute, La Jolla, CA; the Centers for Disease Control and Prevention; and the University of Washington. The ultimate goal is to use knowledge gained from the study to develop vaccines, influenza medications and diagnostic tests to prevent a similar influenza outbreak.

  • Additional information about the Spanish influenza pandemic, including audio interviews, photographs, teacher guides and more can be found through the PBS's The American Experience and Centers for Disease Control, National Vaccine Program Office.

Suggested Reading:

America's Forgotten Pandemic
America's Forgotten Pandemic: The Influenza of 1918

By Alfred W. Crosby.
Published by Cambridge University Press. 1990.
The Great Influenza
The Great Influenza

By John Barry.
Published by Viking Press. 2004.


1926 -- American Home Products Corporation (Wyeth) founded.

Wyeth, founded in the 1860s by John Wyeth and Brother as a small drugstore on Walnut Street in Philadephia, has become one of the leading pharmaceutical and biotechnology companies in the world. From its founding, the Wyeth brothers' drugstore was also a research laboratory (later known as Wyeth Laboratories) that became the first to "advance manufacture" frequently prescribed medicines in bulk.

In 1931, American Home Products (AHP) purchased Wyeth from Harvard University, which had acquired controlling interest in the firm from John Wyeth's son and heir, Stuart, upon his death. Seven decades of mergers and acquisitions (with leading health care companies, including Ayerst, McKenna & Harrison Ltd; A.H. Robins; and Lederle Laboratories) transformed the company into a research powerhouse that markets over-the-counter and prescription medicines in more than 100 countries worldwide. Today, this vast research, development, and marketing complex located in Madison, NJ again bears the Wyeth name.


1928 -- Hoffman-La Roche establishes U.S. plant in Nutley, N.J.

In 1928, the Germany based Hoffman-La Roche, outgrew their New York offices (est. 1905) and located a new U.S. facility in Nutley N.J. to manufacture a wide range of products. In the 1930's Roche becomes the leading supplier of vitamins though its industrial synthesis of vitamin A, B1, B2, E and K1. In the period 1950-1970 pharmaceutical research at Roche diversified with a portfolio ranging from antidepressants and antimicrobials to agents for cancer chemotherapy and inflammatory and cardiovascular diseases. In 1968, the company established the Roche Institute of Molecular Biology as one of the first centers for research and development.

Today, Roche is one of the World's leading healthcare companiesy with a broad range of pharmaceutical products, diagnostics, vitamins and fine Chemicals


1933 -- Thomas Hunt Morgan awarded Nobel Prize in Physiology or Medicine for his chromosome theory of heredity.

Thomas Hunt Morgan Thomas Hunt Morgan pioneered the new science of genetics through experimental research with the fruit fly (Drosophila), laying the foundations for the future of biology. On the basis of fly-breeding experiments he demonstrated that genes are linked in a series on chromosomes and that they determine indentifiable, hereditary traits.

In 1928, Thomas Hunt Morgan transferred to the California Institute of Technology (Caltech) to organize work in biology, and five years later he was awarded the 1933 Nobel Prize in Physiology or Medicine for his chromosome theory of heredity. (Photo: © The Nobel Foundation)


1946 -- John Howard Northrop and Wendell Meredith Stanley awarded Nobel Prize in Chemistry.

John Howard Northop and Wendell Meredith Stanley of the Rockefeller Institute for Medical Research in Princeton, New Jersey were awarded the 1946 Nobel Prize in Chemistry for their preparation of enzymes and virus proteins in a pure form. (Photo: © The Nobel Foundation)

John Howard Northop Wendell Meredith Stanley


1947 -- Transistor invented at AT&T's Bell Laboratories.

John Bardeen William Shockley Walter Brattain The transistor, the invention that marked the dawn of the information age, was invented by John Bardeen, William Shockley and Walter Brattain at AT&T's Bell Laboratories. Bardeen, Shockley and Brattain were awarded the 1956 Nobel Prize in Physics for their discovery of the transistor effect.

Transistors have become an invisible technology that is part of almost every electronic device. Every major information age innovation was made possible by the transistor and its application can be found all around us. (Photos: © The Nobel Foundation)


1953 -- Double helix structure of DNA revealed.

James D. Watson Francis Crick Maurice Wilkins The double helix structure of DNA, the hereditary molecule is revealed by two scientists, James D. Watson and Francis Crick. This is one of the key discoveries of the century. Watson and Crick shared the 1962 Nobel Prize for Physiology and Medicine with Maurice Wilkins for their discoveries concerning the molecular structure of nuclear acids and its significance for information transfer in living material.

Rosalind Franklin, whose work contributed to the discovery, died before this date and the rules do not allow a Nobel Prize to be awarded posthumously. (Photos: © The Nobel Foundation)

Suggested Reading:

The Double Helix
The Double Helix: A Personal Account of the Discovery of the Structure of DNA. By James D. Watson. Published by Touchstone Books. 2001.
DNA
DNA - The Secret to Life. By James D. Watson, Andrew Berry. Published by Knopf. 2003.
Genes, Girls, and Gamow
Genes, Girls, and Gamow: After the Double Helix. By James D. Watson. Published by Vintage. 2003.
Rosalind Franklin
Rosalind Franklin: The Dark Lady of DNA. By Brenda Maddox. Published by Perennial. 2003.
The Third Man of the Double Helix
The Third Man of the Double Helix: The Autobiography of Maurice Wilkins. By Maurice Wilkins. Published by Oxford University Press. 2003.

1958 -- Integrated circuit invented.

Photo of Jack Kilby, inventor of the integrated circuit. Jack Kilby, an engineer at Texas Instruments shows only a transistor and other components on a slice of germanium. This invention (7/16-by-1/16-inches in size), called an integrated circuit, revolutionized the electronics industry. Kilby was awarded the 2000 Nobel Prize in Physics for his invention of the integrated circuit. (Photo: Jack Kilby courtesy of Texas Instruments)


1961 -- President John F. Kennedy expands U.S. Space Program

President John F. Kennedy expands U.S. Space Program Listen to President John F. Kennedy's speech in his historic message to a joint session of the Congress, on May 25, 1961 declared, "...I believe this nation should commit itself to achieving the goal, before this decade is out, of landing a man on the Moon and returning him safely to the Earth." This goal was achieved when astronaut Neil A. Armstrong became the first human to set foot upon the Moon at 10:56 p.m. EDT, July 20, 1969. Shown in the background are, (left) Vice President Lyndon Johnson, and (right) Speaker of the House Sam T. Rayburn. The expansion of the U.S. Space Program resulted in the development of a wide range of technology with enormous benefit to human and animal kind. (Photo: Courtesy of the National Aeronautics & Space Administration)


1969 -- Man walks on the moon.

Neil Armstrong and Buzz Aldrin walk on the Moon. In July of 1969, Neil Armstrong and Buzz Aldrin, American astronauts, made history by becoming the first men to walk on the moon. Listen to Neil Armstrong's first words as he steps onto the lunar surface (66 kb .wav file). (Photo: Courtesy of the National Aeronautics & Space Administration)

An important benefit of the Apollo Lunar Program and other NASA programs is the ever-growing pipeline of technology that improves human and veterinary healthcare diagnostics and therapeutics.


1969 -- Victor McKusick publishes "Mendelian Inheritance in Man".

Victor McKusick, widely acknowledged as the father of medical genetics, spent his career studying the genetic basis of diseases and disorders with the belief that such an understanding could lead to new methods of diagnosis and treatment. He studied, identified, and mapped genes responsible for inherited conditions such as Marfan syndrome and dwarfism (specifically in Amish communities). In 1969, he proposed the idea of mapping the human genome, over 30 years before the Human Genome Project was established.

McKusick, a graduate of Johns Hopkins (M.D. 1946), spent his entire career there and founded the Division of Medical Genetics in 1957, the first research center and clinic of its kind. In 1969 he published the 1st edition of his book "Mendelian Inheritance of Man", one of the most comprehensive collections of inherited disease genes. In 2002, McKusick received the highest scientific honor in the U.S., the National Medal of Science.


1971 -- NASDAQ Stock Market founded.

Nasdaq, founded February 8, 1971, is now the largest U.S. electronic stock market. With approximately 3,300 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. NASDAQ is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media, biotechnology, medical device, and pharmaceutical.

Suggested Reading:


NASDAQ: A History of the Market That Changed the World. By Mark Ingebretsen. Published by Prima Lifestyles. 2002.


1973 -- Recombinant DNA perfected.

Stanley Cohen

The modern era of biotechnology begins when Stanley Cohen of Stanford University and Herbert Boyer of the University of California at San Francisco successfully recombine ends of bacterial DNA after splicing a toad gene in between. They call their accomplishment recombinant DNA, but the media prefers using the term genetic engineering. (Photo: Courtesy Stanley Cohen)


1974 -- Employee Retirement Income Security Act of 1974 (ERISA).

Jacob Javits Pete Williams

John N. Erlenborn, the ranking Republican on the House Committee, was responsible for bringing the Employee Retirement Income Security Act of 1974 (ERISA) to a floor vote, and is one of the ERISA’s "Founding Fathers." Together with Senator Jacob Javits (R-NY), Senator Pete Williams (D-NJ) and Congressman John Dent (D-PA), Erlenborn crafted provisions and participated in negotiations that were instrumental to the enactment of ERISA which was - and remains - the single most important legislation governing employee benefit plans in the United States providing an important source of financial investment for the stock market. (Photos: Jacob Javits and Pete Williams courtesy U.S. Senate Historical Office).


1975 -- Monoclonal antibodies produced.

Niels Jerne Georges Köhler César Milstein In 1975, Georges Köhler and César Milstein, showed how monoclonal antibodies can be generated by isolating individual fused myeloma cells.

The 1984 Nobel Laureate in Medicine was awarded jointly to: Niels Jerne, Georges Köhler and César Milstein for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies. (Photos: © The Nobel Foundation)


1976 -- Genentech, founder of the biotechnology industry, established.

In 1976, Genentech was founded by venture capitalist Robert Swanson and biochemist Dr. Herbert Boyer. In the early 1970s, Boyer and geneticist Stanley Cohen at Stanford University pioneered recombinant DNA technology. Excited by the breakthrough, Swanson called Boyer who agreed to give the young entrepreneur 10 minutes of his time. Swanson's enthusiasm for the technology resulted in a three hour meeting and at its conclusion, Genentech was born.

Within a few short years Swanson and Boyer invented a new industry - biotechnology. In 1980, Genentech issued its Initial Public Offering (IPO) and raised $35 million with an offering that jumped from $35 a share to a high of $88 after less than an hour on the market. The event was one of the largest stock run-ups ever, and that event set the stage for future biotechnolgy industry offerings.

Genentech was initially broadly focused in three areas including food processing, industrial chemicals, and human health care. In 1982, Eli Lilly & Co. which had acquired worldwide rights to Genenetch's recombinant human insulin (1978) received FDA approval to market the product -- the first biotechnology therapeutic to reach the marketplace.

Beginning in 1983, Genentech became solely focused on human therapeutics and diagnostics, and in 1985, Genentech received approval from FDA to market its first product, Protropin® (somatrem for injection) growth hormone for children with growth hormone deficiency — the first recombinant pharmaceutical product to be manufactured and marketed by a biotechnology company. In 1990, Genentech and Roche Holding Ltd. of Basel, Switzerland completed a $2.1 billion merger. Today, Genentech is among the world's leading biotech companies with multiple protein-based products on the market for serious or life-threatening medical conditions.


1977 -- First human gene cloned.

Walter Gilbert Frederick Sanger

Walter Gilbert induced bacteria to synthesize insulin and interferon, and Frederick Sanger published the complete sequence of phage FX174. The 1980 Nobel Laureate in Chemistry was awarded jointly to Frederick Sanger and Walter Gilbert for "for their contributions concerning the determination of base sequences in nucleic acids, and to Paul Berg for his fundamental studies of the biochemistry of nucleic acids, with particular regard to recombinant-DNA. (Photos: © The Nobel Foundation)


1980 -- U.S. Supreme Court ruled man-made organism patentable.

U.S. Supreme Court ruled man-made organism patentable. Diamond v. Chakrabarty, the U.S. Supreme Court upholds five-to-four the patentability of genetically altered organisms, opening the door to greater patent protection for any modified life forms.

In 1972, Chakrabarty, a microbiologist, filed a patent application, assigned to the General Electric Co. for a human-made genetically engineered bacterium capable of breaking down multiple components of crude oil. Because of this property, which is possessed by no naturally occurring bacteria, Chakrabarty's invention was believed to have significant value for the treatment of oil spills. The application asserted 36 claims related to Chakrabarty's invention of "a bacterium from the genus Pseudomonas containing therein at least two stable energy-generating plasmids, each of said plasmids providing a separate hydrocarbon degradative pathway.

Opinions: Chief Justice Warren Burger delivered the opinion of the Court, in which justices Potter Stewart, Harry Blackmun, William Rehnquist, and John Paul Stevens joined. William Brennan filed a dissenting opinion, in which Byron White, Thurgood Marshall, and Lewis Powell joined.


1980 -- Bayh-Dole Act provides for university technology transfer.

Birch Bayh, Senator, Indiana Robert Dole, Senator, Kansas

H.R.6933, Public Law: 96-517, December 12, 1980. A bill to amend title 35 of the United States Code. This Act known as the Bayh-Dole Act provided for the legal transfer of research and technology originating from U.S. universities and federal laboratories to private companies for commercialization. Technology transfer offices are now common in universities and federal laboratories and are the technology foundation for numerous biotechnology and medical device companies. (Photos: Birch Bayh and Robert Dole courtesy U.S. Senate Historical Office)

  • New Jersey Technology Transfer Resources -- A comprehensive listing of technology transfer resources in the state of New Jersey, and select national and international resources.


1990 -- Human Genome Project established.

Human Genome Project Logo The U.S. Human Genome Project was established -- a 13-year effort coordinated by the U.S. Department of Energy and the National Institutes of Health. The project, originally planned to last 15 years, was expected to be completed by 2003 due to rapid technological advances.

Project Goals
  • Identify all the estimated 80,000 genes in human DNA,
  • Determine the sequences of the 3 billion chemical bases that make up human DNA,
  • Store this information in databases,
  • Develop tools for data analysis, and
  • Address the ethical, legal, and social issues that may arise from the project.


1993 -- Biotechnology Industry Organization (BIO) founded.

Biotechnology Industry Organization Biotechnology Industry Organization is the world's largest organization to serve and represent the biotechnology industry. BIO's leadership and service-oriented guidance have helped advance the industry and bring the benefits of biotechnology to people everywhere.


1993 -- Kary B. Mullis awarded Nobel Prize in Chemistry.

Kary B. Mullis of La Jolla, CA and a graduate of the University of California at Berkeley (Ph.D) was awarded the 1993 Nobel Prize in Chemistry for contributions to the developments of methods within DNA-based chemistry, specifically for his invention of the polymerase chain reaction (PCR) method. (Photo: © The Nobel Foundation)

PCR allows scientists to quickly replicate small strands of DNA, greatly simplifying the sequencing and cloning of genes. First presented in 1985, PCR has become one of the most widespread methods of analyzing DNA. Notably, PCR requires the heat-stable enzyme Taq (Thermus Aquaticus) which originated from hot springs located in Yellowstone National Park.

Kary B. Mullis


1995 -- Eric F. Wieschaus awarded Nobel Prize in Medicine.

Eric F. Wieschaus Eric F. Wieschaus of Princeton University was awarded the 1995 Nobel Prize in Physiology or Medicine with Christiane Nüsslein-Volhard and Edward B. Lewis for their discoveries concerning the genetic control of early embryonic development. (Photo: © The Nobel Foundation)


1998 -- The New Jersey "High-Tech Job Retention Act" established

In January 1998, Gov. Christine Todd Whitman (R) approved legislation that will benefit small and emerging technology industries in the state. The High-Tech Job Retention Act was a four-bill economic development package that included an investment tax credit, a transferable research and development tax credit, and extends from 7 years to 15 years the time small companies may carry forward their net operating losses (NOL) and research and development tax credits.


2001 -- Human Genome Project draft sequence published.

Human Genome Project Logo The February 16 issue of Science and February 15 issue of Nature contained the working draft of the human genome sequence (U.S. Human Genome Project). Nature papers included initial analysis of the descriptions of the sequence generated by the publicly sponsored Human Genome Project, while Science publications focused on the draft sequence reported by the private company, Celera Genomics.

  • Human Genome Educational Kit


2009 -- Year of Science launched by the Coalition on the Public Understanding of Science.

Year of Science 2009 Year of Science launched by the Coalition on the Public Understanding of Science (COPUS) will embark on a celebratory journey with you to share how science works, what it is like to be a scientist, and why science matters.

In nearly every state, participants in the celebration will demonstrate how we know about our natural world and why science continues to be so vitally important to our communities, our country, and the world.




Other Resources

  • Suggested Science Education Reading -- A list of select biotechnology and other science related books to help you understand the world of biotechnology.
  • Suggested CEO Reading -- A list of select books recommended by some of the nation's leading chief executive officers from the biotechnology, medical technology and related industry.


Other State & Province BioHistories

Plus the provinces of:

  • Alberta
  • British Columbia


Other Life Science History Resources

  • Albany Medical Center Prize in Medicine and Biomedical Research
  • American Association for the Advancement of Science
  • Chemical Heritage Foundation
  • Food & Drug Administration
  • Gotham Prize for Cancer Research
  • International Balzan Foundation
  • International Museum of Surgical Science
  • Lasker Foundation
  • National Academy of Sciences
  • National Health Museum
  • National Institutes of Health History, Office of
  • National Medal of Science
  • Prix Galien USA
  • The Nobel Foundation
  • The World Food Prize


Tell us about New Jersey's BioHistory. If you are aware of a notable event, person,
organization/company or accomplishment that we should include,
please e-mail: BioHistory@InfoResource.org


New Jersey BioHistory(TM) and New Jersey BioEvolution(TM) © 2008 Info.Resource, Inc.

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2023 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

NewJerseyLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of New Jersey.